Your Research—Our Lives

  • Pat Cody
Conference paper


DES Action is a consumer group representing those exposed in utero to diethylstilbestrol and their mothers. We work to educate the public and health-care providers about DES, to provide medical information and referrals, to monitor research, and to act as advocates for the DES-exposed. DES Action has 30 chapters in 22 states in the United States as well as foreign affiliates in Australia, Canada, England, France, Ireland, and the Netherlands. Research reports on such major concerns as fertility and pregnancy and risks for breast cancer make possible our special publications on these topics. As the DES-exposed cohort ages, there remain some major unanswered questions: effects on the children of DES daughters and sons? Extent of immune system impairment? Effects on the endocrine system? Research into these questions will shed light on anecdotally observed health effects from DES exposure.


European Economic Community Foreign Affiliate Synthetic Estrogen Immune System Impairment Boston Collaborative Drug Surveillance Program 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Greenberg, ER et al (1984) Breast Cancer in Mothers Given Diethylstilbestrol in Pregnancy. N Engl J Med 311: 1393–1398.PubMedCrossRefGoogle Scholar
  2. 2.
    Gill, WB et al (1979) Association of Diethylstilbestrol Exposure in Utero with Cryptochidism, Testicular Hypoplasia and Semen Abnormalities. J of Urology 122: 36–39.Google Scholar
  3. 3.
    Blair, PB (1981) Immunologic Consequences of Early Exposure of Experimental Rodents to DES. Editors Herbst AL and Bern HA in Developmental Effects of Diethylstilbestrol in Pregnancy, Thieme and Stratton, 167–178.Google Scholar
  4. 4.
    Wigard, DL and Turiel J (1988) Long-term Effects of Exposure to Diethylstilbestrol. Western J Med 149: 551–554.Google Scholar
  5. 5.
    Nouer, KL et al (1988) Increased occurrence of autoimmune disease among women exposed in utero to diethylstilbestrol. Fertility and Sterility 49: 1080–1082.Google Scholar
  6. 6.
    Smith, OW (1948) Diethylstilbestrol in the prevention and treatment of complications of pregnancy. Am J Ob Gyn 56: 821–833.Google Scholar
  7. 7.
    Dieckmann, WJ et al (1953) Does the administration of diethylstilbestrol during pregnancy have therapeutic value? Am J Ob Gyn 66: 1062–1080.Google Scholar
  8. 8.
    The Wall St. Journal, Dec. 23, 1975.Google Scholar

Copyright information

© Springer-Verlag New York, Inc. 1992

Authors and Affiliations

  • Pat Cody

There are no affiliations available

Personalised recommendations